Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Posted on: May/19/2025 02:14:15
AbCellera anticipates starting Phase 1 clinical trial Q3-2025
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176206257
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.